Orthopy Health
Orthopy Health is a Hamburg-based digital therapeutics company that operates the Orthopy App, a CE-marked Class I medical device providing personalized rehabilitation programs, exercise guidance, and education for patients recovering from knee injuries such as ACL ruptures and meniscus damage.
- Company typePrivate
- Founded2020
- HeadquartersHamburg, Germany
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What Orthopy Health does
Orthopy Health GmbH is a Hamburg-based digital health company founded in October 2020 that develops the Orthopy App, a CE-marked Class I medical device under EU MDR 2017/745, delivering digital therapy accompaniment for patients recovering from knee injuries (ACL ruptures, meniscus injuries, and ankle distortions). The mobile application provides personalized training programs derived from physician-prescribed parameters (diagnosis, treatment phase, movement range, load specifications), video/audio/text-guided exercises, a prehabilitation module for pre-surgical preparation, symptom and progress logging, push-notification reminders, and FHIR/MIO-compliant data export. Educational content is delivered through the Orthopedia knowledge base integrated into the app ecosystem.
The company's commercial model is currently transitional: the primary access route is free participation in the Versorgungsbeobachtung (observational study) program, with secondary self-pay purchase and a Rezeptservice that supports private health insurance reimbursement submissions. Orthopy is not currently listed in the DiGA directory and therefore cannot be reimbursed by statutory health insurance. Go-to-market combines a sales-led motion (physicians and physiotherapists prescribing or recommending the app via the Fachkreise portal) with self-serve patient downloads on iOS and Android, supported by content marketing, clinical study publications, and social media.
As of 2025, Orthopy supports over 11,000 patients with a team of 20+ employees and operates from Hamburg (headquarters and Health Innovation Port). The company holds ISO 13485, ISO 27001, ISO 27017, ISO 27018, GDPR, BSI TR-03161, and DiGAV-aligned compliance certifications. In 2025, Orthopy entered an exclusive strategic partnership with Enovis, a global orthopedic medical technology company, to scale distribution and integrate the app into Enovis's product portfolio, while concurrently conducting the AMORE randomized controlled trial across 8 German study centers to build DiGA-grade clinical evidence.
Orthopy Health firmographics
Firmographics- Name
- Orthopy Health
- Legal name
- Orthopy Health GmbH
- Website
- https://orthopy.de
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Orthopy Health is a Hamburg-based digital therapeutics company that operates the Orthopy App, a CE-marked Class I medical device providing personalized rehabilitation programs, exercise guidance, and education for patients recovering from knee injuries such as ACL ruptures and meniscus damage.
- Ownership category
- akta.pro rank
Orthopy Health industry classification
Industry- Product category
- Digital Therapeutics — Orthopedic Rehabilitation Software
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Other Health Practitioners (6213), Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Orthopedics & Sports Medicine Telemedicine Platforms (HLALAGAO)
- akta.pro secondary industries
- Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ), SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
Keywords
Where Orthopy Health is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Orthopy Health business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Versorgungsbeobachtung (Observational Study): Currently the primary access model. Patients participate in a voluntary observational study, receiving the app free of charge. The study collects health outcomes data to evaluate the app's effectiveness and support future regulatory and reimbursement pathways.
- Private Health Insurance Reimbursement: Private health insurance patients can submit receipts for potential reimbursement through the Rezeptservice. The company facilitates submission but does not guarantee reimbursement.
- Direct Self-Pay Purchase: Patients can purchase the app directly as self-payers. A purchase agreement is formed upon payment, with a personal, non-transferable right to use the app for the specified duration.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Annual | Versorgungsbeobachtung - Free access for study participants |
| Subscription | Annual | Direct Purchase - Self-pay option |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Orthopy Health product offering
Product offeringCore offering
Orthopy Health sells the Orthopy App, a CE-marked Class I medical device mobile application (iOS and Android) that delivers personalized, evidence-based digital therapy accompaniment for patients with knee injuries including ACL ruptures, meniscus damage, and ankle distortions. The app provides individualized training programs with video/audio-guided exercises, prehabilitation modules, patient education content, progress tracking, symptom logging, and interoperable data export for healthcare providers. Patients access the app primarily through the Versorgungsbeobachtung observational study (free), private health insurance reimbursement, or direct self-pay purchase.
Product overview
Orthopy Health offers the Orthopy App as its primary core product — a certified digital therapeutic (Class I medical device under MDR) designed for patients with knee injuries. The app provides individualized physiotherapy training programs, guided exercise videos, patient education content, and progress tracking. The portfolio includes Orthopedia, a knowledge platform with educational articles about injuries and recovery. The company also conducts clinical research through the AMORE study to validate the app's effectiveness for ACL and meniscus injuries. The app is available as a mobile application for iOS and Android, with interoperability support for FHIR/MIO data export standards.
Differentiator
Problem solved
Functional benefit
Products and services
- Orthopy App A CE-marked Class I medical device mobile app (iOS and Android) that delivers individualized digital therapy for patients with knee injuries (ACL ruptures, meniscus damage, ankle distortions). Provides personalized training programs, prehabilitation modules, video/audio-guided exercises, patient education, progress tracking, symptom logging, and FHIR/MIO-compliant data export. Distributed through app stores, observational study enrollment, private insurance reimbursement, and self-pay.
- Orthopedia A knowledge hub providing educational articles about knee anatomy, injury types (ACL, meniscus), treatment options, recovery processes, and self-care techniques, integrated within the Orthopy App and website ecosystem for patient education.
Quantifiable outcome
- Statistically significant pain reduction (p=0.0005 at t1, p=0.0068 at t2, p=0.01 at t4)
- +3 more outcomes
Companies that use Orthopy Health
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
Orthopy Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Orthopy Health partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- EnoviscoreEnovis, a global leader in orthopedics and medical technology, is the exclusive partner of Orthopy Health GmbH. For Enovis, this partnership represents an expansion of their product portfolio and a deliberate step to integrate digital innovations into their healthcare offerings, sustainably improving patient care.
- Ormed GmbHminorOrmed GmbH (Bötzlinger Straße 90, 79111 Freiburg) is a specialized service provider engaged by Orthopy for the administrative processing of DiGA prescriptions and customer support. A strict data processing agreement (Auftragsverarbeitung) is in place.
- ARCUS KlinikencoreClinical study center for AMORE clinical trial investigating digital therapy for ACL and meniscus injuries. Located in Pforzheim, Germany. Study led by Dr. Christian Sobau.
- Praxisklinik 2000 (Freiburg)coreClinical study center for AMORE clinical trial. Located in Freiburg, Germany. Study led by Prof. Dr. Gerrit Bode.
- ACOS-Praxisklinik (Heilbronn)minorClinical study center conducting the meniscus study only. Located in Heilbronn, Germany. Study led by Dr. Oliver Eckardt.
- Orthopädische Klinik Stuttgart-BotnangminorClinical study center for AMORE clinical trial. Located in Stuttgart, Germany. Study led by Dr. Nikolas Kolbe.
- Malteser Waldkrankenhaus (Erlangen)minorClinical study center for AMORE clinical trial. Located in Erlangen, Germany. Study led by Prof. Dr. Thomas Tischer and Dr. Alvaro Gallardo.
- St. Vinzenz Allgäu (Pfronten)minorClinical study center for AMORE clinical trial. Located in Pfronten, Germany. Study led by Dr. Björn Drews.
- Heinrich-Braun-Klinikum (Zwickau)minorClinical study center for AMORE clinical trial. Located in Zwickau, Germany. Study led by Dr. Franziska Kupferschmied.
- Klinik Manhagen (Großhansdorf)minorClinical study center for AMORE clinical trial. Located in Großhansdorf, Germany. Study led by Dr. Matthias Gebhardt.
Scale indicators3 records
Recent moves10 records
Expansion highlights6 records
Orthopy Health competitors and assessment
Company assessmentDirect peers
- Kaia Health: Kaia Health offers app-based digital therapeutic programs for musculoskeletal pain, including back pain and knee/hip conditions. Comparable to Orthopy in offering personalized exercise therapy via mobile app with a clinical evidence base, though it operates across multiple indications and geographies.
- Caspar Health: Caspar Health provides digital rehabilitation platforms connecting patients with therapists for post-surgical and orthopedic rehabilitation, available in Germany and other European markets. Comparable to Orthopy in targeting orthopedic rehabilitation through digital channels, with a hybrid human-plus-digital model.
- Vivira Health Lab: Vivira is a German DiGA-listed digital therapeutic for back pain, offering prescribed app-based exercise therapy with physician monitoring. Directly comparable to Orthopy as a German musculoskeletal digital therapeutic pursuing the same DiGA prescription pathway and patient demographic.
- Selfapy: Selfapy is a German digital health company offering DiGA-listed courses for conditions including back pain, depression, and insomnia. Comparable to Orthopy as a German-language digital therapeutic pursuing the same DiGA reimbursement pathway, though focused on different indications.
- Sword Health: Sword Health is a digital MSK care provider offering virtual physical therapy with AI-guided exercise programs. Comparable to Orthopy in targeting musculoskeletal rehabilitation through digital tools, with a broader scope including back, hip, knee, and pelvic conditions, and a stronger commercial presence in the US and EU employer/payer market.
Broad incumbents
- Enovis: Enovis is a global medical technology company specializing in orthopedic implants, surgical equipment, and recovery products, and is Orthopy's exclusive strategic partner. Enovis is comparable as an incumbent orthopedic player integrating digital health capabilities, and its partnership with Orthopy creates a channel and validation anchor that no other peer has at this scale.
- Omada Health: Omada Health is a US digital chronic care company offering virtual care programs for diabetes, hypertension, and musculoskeletal conditions. Comparable to Orthopy as a regulated digital therapeutic with clinical evidence, though broader in scope and more commercially mature.
- Hinge Health: Hinge Health is one of the largest digital MSK platforms globally, offering app-based exercise therapy, coaching, and wearable sensors for back, knee, hip, and other joint conditions. While US-focused and broader in scope than Orthopy's knee-only focus, it represents the scaled incumbent model of digital orthopedic therapy that Orthopy aspires to in Europe.
- medi GmbH (orthopedic division): medi is a German medical device manufacturer with significant orthopedic braces, supports, and compression products. As an established German orthopedic medical device incumbent with direct surgeon relationships, medi represents a potential competitive or partnership counterpart to Orthopy in the orthopedic care pathway.
Emerging players
- Re.flex: Re.flex offers a digital MSK solution combining motion-tracking sensors with a smartphone app for knee and hip rehabilitation. Comparable to Orthopy in targeting knee rehabilitation via mobile app, with a distinguishing motion-sensor hardware component.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Orthopy Health social profiles
Digital presenceOrthopy Health compliance and trust
Trust signalCompliance5 records
Orthopy Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Orthopy Health leadership team
Management profileNumber of profiles
Profiles7 records
Orthopy Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Orthopy Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Orthopy Health
What does Orthopy Health do?
Orthopy Health sells the Orthopy App, a CE-marked Class I medical device mobile application (iOS and Android) that delivers personalized, evidence-based digital therapy accompaniment for patients with knee injuries including ACL ruptures, meniscus damage, and ankle distortions. The app provides individualized training programs with video/audio-guided exercises, prehabilitation modules, patient education content, progress tracking, symptom logging, and interoperable data export for healthcare providers. Patients access the app primarily through the Versorgungsbeobachtung observational study (free), private health insurance reimbursement, or direct self-pay purchase.
Is Orthopy Health a public or private company?
Orthopy Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Orthopy Health founded?
Orthopy Health was founded in 2020. It employs 11 to 50 people.
Where is Orthopy Health based?
Orthopy Health is headquartered in Hamburg, Germany, in the Europe region.
How does Orthopy Health make money?
Three revenue lines are on record. Versorgungsbeobachtung (Observational Study) is the primary driver. The others are private Health Insurance Reimbursement and direct Self-Pay Purchase.
Who are Orthopy Health's main competitors?
Direct peers on record are Kaia Health, Caspar Health, Vivira Health Lab, Selfapy and Sword Health. Broad incumbents are Enovis, Omada Health, Hinge Health and medi GmbH (orthopedic division). Re.flex is listed as an emerging player.
Does Orthopy Health have an API?
No public API is recorded for Orthopy Health.
What industry is Orthopy Health in?
Orthopy Health's product category is Digital Therapeutics — Orthopedic Rehabilitation Software. Its primary akta.pro industry code is HLALAGAO, Orthopedics & Sports Medicine Telemedicine Platforms, with a secondary code of HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up). Its NAICS code is 62134 and its SIC code is 3842.